CERS
Medical Devices · Healthcare
CEO, Chairman, Board Member
2011-01-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Cerus Corp publishes a filing, an earnings call transcript or a press release.
Get CERS alertsWilliam M. Greenman is recorded as Chairman at Cerus Corp (CERS) since June 20, 2025, Board Member at Cerus Corp (CERS) since January 1, 2011 and CEO at Cerus Corp (CERS). The newest filing on record that lists William M. Greenman as CEO and Board Member at Cerus Corp (CERS) is dated April 22, 2026. Cerus Corp reported in an 8-K filed June 3, 2026 that William M. Greenman was appointed Director, effective June 2, 2026. Cerus Corp reported in an 8-K filed June 23, 2025 that William M. Greenman was appointed chair of the Board, effective June 20, 2025. The proxy statement of Cerus Corp reports total compensation of $3,794,657 for William M. Greenman in fiscal 2025, including a base salary of $793,750. Disclosed compensation is on record for 9 fiscal years. William M. Greenman has spoken on 1 earnings call across 1 company, most recently for Cerus Corp on August 5, 2025. Cerus Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cerus Corp includes Vivek Jayaraman (CEO, COO and Board Member), William "Obi" Greenman (Chairman), William “Obi” Greenman (Chairman) and 7 others.
“The Company's stockholders elected each of the two nominees named below to the Board of Directors to serve until the 2029 Annual Meeting of Stockholders or until his or her respective successor has been duly elected and qualified.”
“on June 20, 2025, the Board appointed William M. Greenman, the Company's President and Chief Executive Officer and a member of the class of directors whose terms of office expire at the Company's 2026 annual meeting of stockholders, to serve as chair of the Board and Frank Witney, Ph.D., a member of the class of directors whose terms of office expire at the Company's 2027 annual meeting of stockholders, to serve as the Board's lead independent director, in each case effective immediately.”
“I would like to open the call with a review of the highlights from the second quarter as well as our outlook for the duration of the year.”
2025-06-20–present
2011-01-01–present
Last confirmed April 22, 2026
Start not stated–present
Last confirmed April 22, 2026
CERS
Medical Devices · Healthcare
CEO, Chairman, Board Member
2011-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cerus Corp (CERS) | President and Chief Executive Officer | $793,750 | $3,794,657 |
| 2024 | Cerus Corp (CERS) | President and Chief Executive Officer | $770,000 | $2,975,617 |
| 2023 | Cerus Corp (CERS) | President and Chief Executive Officer | $763,750 | $3,660,472 |
| 2022 | Cerus Corp (CERS) | President and Chief Executive Officer | $732,083 | $5,263,599 |
| 2021 | Cerus Corp (CERS) | President and Chief Executive Officer | $696,375 | $5,182,371 |
| 2020 | Cerus Corp (CERS) | President and Chief Executive Officer | $669,792 | $4,520,750 |
| 2019 | Cerus Corp (CERS) | President and Chief Executive Officer | $645,000 | $3,270,179 |
| 2018 | Cerus Corp (CERS) | President and Chief Executive Officer | $616,667 | $2,983,442 |
| 2017 | Cerus Corp (CERS) | President and Chief Executive Officer | $596,667 | $2,123,573 |